Posts

In another reversal, FDA gives uniQure accelerated approval path for Huntington's gene therapy

on

Protara Therapeutics Receives FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Lymphatic Malformations

on

FDA Breakthrough Designations Lead to Priority Reviews, Report Finds

on

Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push

on

Genmab CEO on the $8B Acquisition of Merus: Strategy Behind the 'Very Fair' Deal and Plans to Polish a Rough Diamond

on

Sanofi's MS Drug Tolebrutinib Faces FDA Delay Amid Extended Review

on

Avidity Touts Functional Improvements for DMD Therapy, Clearing Way to FDA

on

Bausch Health to Acquire DURECT and Breakthrough Liver Disease Candidate Larsucosterol for $63M Upfront

on

A New Dawn for Psychedelics: Compass Pathways Nears Major Phase 3 Psilocybin Results

on

Kura Oncology's Ziftomenib Achieves Phase 2 Success in AML, Paving Way for Dual-Track Phase 3 Program

on